INFINITY PHARMACEUTICALS INC (INFI)

US45665G3039 - Common Stock

0.0447  -0.04 (-46.98%)

After market: 0.04 0 (-10.51%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.7M
-43.33%		1.858M
9.29%		2.593M
39.56%		2.754M
6.21%
EBITDA
YoY % growth
-38M
16.48%		-44.603M
-17.38%		-44.386M
0.49%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-38.5M
15.75%		-45.083M
-17.10%		-44.844M
0.53%		-48.923M
-9.10%
Operating Margin
-2,264.71%-2,426.43%-1,729.43%-1,776.44%
EPS
YoY % growth
-0.67
18.29%		-0.53
20.90%		-0.50
5.66%		-0.47
6.16%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.12
-2.00%
Revenue
Q2Q % growth		714K
0.28%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-10.681M
1.83%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 -0.12
14.29%		-0.11-0.01-12.04%
Q4 2022
Q2Q % growth		 -0.11
15.38%		-0.03-0.08-223.56%
Q3 2022
Q2Q % growth		 -0.12 -0.06-0.06-96.08%
Q2 2022
Q2Q % growth		 -0.13 -0.150.0212.70%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 583K
-15.01%		714K-131K-18.35%
Q1 2023
Q2Q % growth		 731K
12.12%		306K425K138.89%
Q4 2022
Q2Q % growth		 543K
20.40%		612K-69K-11.27%
Q3 2022
Q2Q % growth		 712K
66.36%		6.312M-5.6M-88.72%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4% 0% 5.15%
Revenue0% 100% 0% 100%